Valuation (34%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -29.90 | -39.00 |
| PEG Ratio (TTM) | -0.67 | 1.77 |
| P/S Ratio (TTM) | 0.69 | 2.13 |
| P/B Ratio (TTM) | 3.03 | 0.60 |
| P/FCF Ratio (TTM) | 9.93 | 27.79 |
| Price to 5YR AVG Earnings Ratio | -189.08 | -80.82 |
| Price to 5YR AVG FCF Ratio | 38.53 | 9.85 |
Profitability (8%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -3.06% | 1.03% |
| ROE (TTM) | -10.60% | 2.01% |
| Net Profit Margin (TTM) | -2.29% | 2.69% |
| ROIC 5YR AVG | 1.82% | -0.25% |
Growth (73%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 5.93% | 224.53% | -398.30% |
| Revenue | 0.04% | 18.57% | 13.42% |
| Net Income | 6.23% | 267.63% | -429.06% |
| Cash Flow | 83.80% | 27.06% | 22.46% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.96 | 1.06 |
| Quick Ratio (TTM) | 0.64 | 0.74 |
| D/E Ratio (TTM) | 0.94 | 0.94 |
| Interest Coverage (TTM) | 0.72 | 4.98 |
| Piotroski F-Score | 4 | 5 |
| Altman Z-Score | 1.94 | 1.92 |
| LTL to 5YR AVG FCF | 10.83 | -0.16 |
| Shares Outstanding Growth 5YR AVG | 13.68% | 9.79% |